Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001213900-21-049820)

Filing Details

Accession Number:: 0001213900-21-049820
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-09-24 17:00:49
Reporting Period:: 2021-09-22

Accepted Time:: 2021-09-24 17:00:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1553643	Relmada Therapeutics Inc.	RLMD	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1117167	J Charles Casamento	C/O Relmada Therapeutics, Inc. 2222 Ponce De Leon Blvd, 3Rd Floor Coral Gables, FL 33134		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-09-22	10,000	$4.60	16,600	No	4	M	Direct
Common Stock	Disposition	2021-09-22	1,900	$29.00	14,700	No	4	S	Direct
Common Stock	Disposition	2021-09-22	3,300	$29.00	11,400	No	4	S	Direct
Common Stock	Disposition	2021-09-22	1,400	$29.00	10,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Options to purchase common stock	Disposition	2021-09-22	1,900	$0.00	1,900	$3.24

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
97,311	2017-10-20	2027-10-20	No	4	M	Direct

Footnotes

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 29, 2020.
The options vest from the date of grant in equal quarterly increments of 6.25% over a four year period..
Not applicable